AbbVie vs Johnson & Johnson
AbbVie (ABBV), health care, and Johnson & Johnson (JNJ), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Johnson & Johnson is worth $675.5B on the stock market and AbbVie $518.6B: Johnson & Johnson is valued at 30% more. AbbVie trades at 50.5 times earnings and Johnson & Johnson at 42.6. Over the past year AbbVie's share price has moved +25.9% and Johnson & Johnson's +41.3%.
Key facts
- AbbVie market value
- $518.6B
- Johnson & Johnson market value
- $675.5B
- AbbVie P/E
- 50.5
- Johnson & Johnson P/E
- 42.6
- AbbVie revenue
- $61.2BFY to 2025-12-31
- Johnson & Johnson revenue
- $94.2BFY to 2025-12-28
- Superinvestors holding both
- 10
Market values as of .
| Measure | AbbVie | Johnson & Johnson |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-28 |
| Size | ||
| Market cap | $518.6Blower | $675.5Bhigher |
| Revenue | $61.2Blower | $94.2Bhigher |
| Earnings | $4.2Blower | $26.8Bhigher |
| Employees | 57,000lower | 138,200higher |
| Total assets | $134Blower | $199.2Bhigher |
| Valuation | ||
| P/E | 50.5higher | 42.6lower |
| P/S | 8.5higher | 7.2lower |
| P/B | — | 8.3 |
| Dividend yield | 2.35%higher | 1.87%lower |
| Profitability | ||
| Operating margin | 24.6% | — |
| Balance sheet | ||
| Net assets | -$3.3Blower | $81.5Bhigher |
| Total liabilities | $137.2Bhigher | $117.7Blower |
| Total debt | $67.5Bhigher | $47.9Blower |
| Cash on hand | $5.2Blower | $19.7Bhigher |
| Price change | ||
| Today | -0.39%higher | -0.68%lower |
| 1 year | +25.9%lower | +41.3%higher |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (10)
- Fred DiSanto1.5% / 1.1%
- Ken Fisher0.8% / 1.1%
- Ken Griffin0.5% / 0.2%
- Cliff Asness0.2% / 0.3%
- Mairs & Power team0.1% / 0.9%
- Jensen team0.1% / 0.1%
- Murray Stahl0.1% / 0.1%
- Thomas Russo<0.1% / <0.1%
- Howard Gleicher<0.1% / <0.1%
- Rajiv Jain<0.1% / <0.1%
AbbVie only (5)
- Larry Robbins0.7%
- David Shaw (founder)0.3%
- Israel Englander0.3%
- Lew Sanders0.1%
- Bill Nygren<0.1%
Johnson & Johnson only (13)
- Tweedy, Browne team4.1%
- Stephen Yacktman4.0%
- Jeremy Grantham (co-founder)4.0%
- Mark Boyar2.6%
- Tom Gayner1.3%
- Ray Dalio (founder)0.7%
- Andrew Spokes0.7%
- Charles Brandes (founder)0.3%
- Mario Gabelli0.2%
- George Soros0.1%
- John Rogers0.1%
- Christopher Bloomstran<0.1%
- Dodge & Cox team<0.1%
Percentages are each holding's share of that investor's reported portfolio (under "Both": AbbVie / Johnson & Johnson). Who owns ABBV · Who owns JNJ
More on AbbVie
Further comparisons
AbbVie against its closest peers
Johnson & Johnson against its closest peers
Learn
Questions and answers
Which is bigger, AbbVie or Johnson & Johnson?
By market value, Johnson & Johnson is the larger: $675.5B against $518.6B for AbbVie. By revenue in its latest fiscal year, Johnson & Johnson is the larger: $94.2B against $61.2B for AbbVie.
Which has the higher P/E ratio?
AbbVie: 50.5, against 42.6 for Johnson & Johnson. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher dividend yield?
AbbVie: 2.35%, against 1.87% for Johnson & Johnson. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which has more debt?
AbbVie: $67.5B, against $47.9B for Johnson & Johnson. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both AbbVie and Johnson & Johnson?
In their latest 13F filings, Fred DiSanto, Ken Fisher, Ken Griffin, Cliff Asness, Mairs & Power team, Jensen team, Murray Stahl, Thomas Russo, Howard Gleicher and Rajiv Jain hold both.
Cite this page
Funkfolio, “AbbVie vs Johnson & Johnson”, data as of 17 November 2026. https://funkfolio.com/compare/abbv-vs-jnj
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.